Published

Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Date: 2020-01-13
Source: PubMed
DOI: 10.1002/chem.201904363
PubMed: 31729089

Authors

Blei F Dörner S Fricke J Baldeweg F Trottmann F Komor A Meyer F Hertweck C Hoffmeister D

Watch author

Derived topics and classifications

psilocybin Brain Imaging Mechanism of Action Aging Metabolomics Other

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy2026-06-02 Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms2025-11-25 Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.2020-01-13

Related papers

Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19